AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Crinetics Pharmaceuticals, Inc.

$84.95 +$38.22 (+81.79%)
NASDAQ · 01 Sep 2026 13:30 UTC
Previous Close
$84.95
Day Range
$84.95 - $84.95
Year Range
$32.3$85.01
Market Cap
9B
AVG Volume
3.26M
Trailing/Forward PE
-16.82/-
PEG ratio
1.87
Dividend Yield
-
Next Earnings Date
2026-11-05
Primary Exchange
NASDAQUS
Revenue (USD) · A
02M4M6M8M201720182019202020212022202320242025
CRNX Revenue (USD) by year
PeriodRevenue (USD)
20257.7M
20241.04M
20234.01M
20224.74M
20211.08M
20200
20190
20180
20170
Net Income (USD) · A
-600M-400M-200M0201720182019202020212022202320242025
CRNX Net Income (USD) by year
PeriodNet Income (USD)
2025-465.32M
2024-298.41M
2023-214.53M
2022-163.92M
2021-107.64M
2020-73.81M
2019-50.42M
2018-27.11M
2017-9.16M
Operating Income (USD) · A
-600M-400M-200M0201720182019202020212022202320242025
CRNX Operating Income (USD) by year
PeriodOperating Income (USD)
2025-516.77M
2024-338.85M
2023-222.61M
2022-167.88M
2021-107.7M
2020-74.95M
2019-53.83M
2018-28.71M
2017-9.13M
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book
Crinetics Pharmaceuticals, Inc.
CRNX
Stockpicker

Video analysis: CRNX

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: CRNX

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.